The relevance of POCT in healthcare

  • Ralf Junker
  • Astrid Petersmann
  • Peter B. Luppa


Near-patient laboratory diagnostics has a long history and is now an indispensable part of clinical medicine. On the one hand, devices incorporating POCT fulfill the medical rationale of shortening the time from blood draw to treatment decision. On the other, POCT analyzers can also be provided for organizational reasons, rendering feasible options like the ability to improve clinical processes or enhance patient satisfaction. Considering the numerous tests that are freely available, strict quality assurance is required and mandatory for most methods.


  1. 1.
    Bietenbeck A, Junker R, Luppa PB (2015) Central laboratory service and Point-of-Care Testing in Germany – From conflicting notions to complementary understandings. Point Care J Near-Patient Test Technol 14: 1–11Google Scholar
  2. 2.
    Bundesärztekammer (German Medical Association) (2014) Guideline of the German Medical Association for the Quality Assurance of Clinical Laboratory Testing (Rili-BÄK 2014). Dtsch Ärztebl 111:A1583–1618Google Scholar
  3. 3.
    Doyle NM, Levison JE, Gardner MO (2005) Rapid HIV versus enzyme-linked immunosorbent assay screening in a low-risk Mexican American population presenting in labor: a cost-effectiveness analysis. Am J Obstet Gynecol 193: 1280–1285CrossRefPubMedGoogle Scholar
  4. 4.
    Drenck N (2001) Point of care testing in critical care medicine: The clinician’s view. Clin Chim Acta 307: 3–7CrossRefGoogle Scholar
  5. 5.
    Gruszecki AC, Hortin G, Lam J et al. (2003) Utilization, reliability, and clinical impact of point-of-care testing during critical care transport: Six years of experience. Clin Chem 49: 1017–1019CrossRefPubMedGoogle Scholar
  6. 6.
    Hänecke P, Haeckel R, Koschinsky T, Luppa P, Schlebusch H, Wahl HG (2004) Qualitätssicherung in der patientennahen Sofortdiagnostik (Point-of-Care Testing) im Krankenhaus: Muster für eine hausinterne Richtlinie. J Lab Med 28: 256–263Google Scholar
  7. 7.
    Jani IV, Peter TF (2013) How Point-of-Care Testing could drive innovation in global health. N Engl J Med 368: 2319–2324CrossRefPubMedGoogle Scholar
  8. 8.
    Kost GJ, Tran NK. Effects of point-of-care testing on time, process, decision making, treatment and outcome. In: Kost GJ (ed) (2002) Principles and practice of point-of-care testing. Lippincott Williams & Wilkins, Philadelphia, pp 605–611Google Scholar
  9. 9.
    Kost GJ, Tran NK (2002) The economics of point-of-care testing. In: Kost GJ (ed) Principles and practice of point-of-care testing. Lippincott Williams & Wilkins, Philadelphia, pp 613–622Google Scholar
  10. 10.
    Kost GJ (2002) Controlling economics, preventing errors, and optimizing outcome in point-of-care testing. In: Kost GJ (ed) Principles and practice of point-of-care testing. Lippincott Williams & Wilkins, Philadelphia, pp 577–600CrossRefGoogle Scholar
  11. 11.
    Kost GJ (2002) Goals, guidelines, and principles for point-of-care testing. In: Kost GJ (ed) Principles and practice of point-of-care testing. Lippincott Williams & Wilkins, Philadelphia, pp 3–12Google Scholar
  12. 12.
    Luppa P, Junker R (2010) Verantwortung für die Durchführung der Qualitätssicherung einer dezentral organisierten Laboratoriumsdiagnostik im Krankenhaus. Klin. Chemie Mitteilungen 41:205–8Google Scholar
  13. 13.
    Luppa PB, Müller C, Schlichtiger A, Schlebusch H (2011) Point-of-care testing (POCT): Current techniques and future perspectives. Tr Anal Chem 30: 887–898CrossRefGoogle Scholar
  14. 14.
    Mahtabjafari M, Masih M, Emerson AE (2001) The value of pharmacist involvement in a point-of-care service, walk-in lipid screening program. Pharmacotherapy 21: 1403–1406CrossRefGoogle Scholar
  15. 15.
    National Academy of Clinical Biochemistry (NACB) (2007) Practice guidelines: Evidence-based practice for point-of-care testing. Point of care 6: 213–217Google Scholar
  16. 16.
    Peterson GM, Fitzmaurice KD, Naunton M, Vial JH, Stewart K, Krum H (2004) Impact of pharmacist-conducted home visits on the outcomes of lipid-lowering drug therapy. J Clin Pharm Ther 29: 23–30CrossRefPubMedGoogle Scholar
  17. 17.
    Price CP, St. John A (2014) Innovation in healthcare. The challenge for laboratory medicine. Clin Chim Acta 427: 71–78CrossRefGoogle Scholar
  18. 18.
    Robert LS, Edward HL (2007) Point-of-care testing: Guidelines and challenges. NC Med J 68: 132–135Google Scholar
  19. 19.
    Schlüter B, Junker R (2003) Labordiagnostik – Schneller ist nicht immer besser. Dtsch Ärztebl 100: A87–A89Google Scholar
  20. 20.
    Scott MG (2000) Faster is better – It’s rarely that simple! Clin Chem 46: 441–442Google Scholar
  21. 21.
    Till LT, Voris JC, Horst JB (2003) Assessment of clinical pharmacist management of lipid-lowering therapy in a primary care setting. J Manag Care Pharm 9: 269–273CrossRefPubMedGoogle Scholar
  22. 22.
    van Heyningen C, Watson ID, Morrice AE (1999) Point-of-care testing outcomes in an emergency department. Clin Chem 45: 437–438Google Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  • Ralf Junker
    • 1
  • Astrid Petersmann
    • 2
  • Peter B. Luppa
    • 3
  1. 1.Universitätsklinikum Schleswig-HolsteinInstitut für Klinische ChemieKielGermany
  2. 2.Universitätsmedizin GreifswaldInstitut für Klinische Chemie und LaboratoriumsmedizinGreifswaldGermany
  3. 3.Klinikum rechts der TU MünchenInstitut für Klinische Chemie und PathobiochemieMünchenGermany

Personalised recommendations